BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Micro Imaging Technology, Inc. (MMTC)'s Eye on the Future


1/31/2013 9:25:46 AM

SAN CLEMENTE, CA--(Marketwire - January 31, 2013) - Micro Imaging Technology, Inc. (OTCQB: MMTC) MIT has developed and patented the MIT 1000, a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. This technology will identify bacteria in minutes at a significantly lower cost per test compared to conventional methods.

Jeffrey Nunez, MIT's Chairman and CEO, stated, "This press release is to provide an update concerning our achievements over the past year and a look ahead for 2013."

  • We received significant financial backing from our newest Board member, Gregg Newhuis, and others, allowing us to concentrate all of our efforts on moving our technology and marketing strategy forward.

  • We dramatically improved our balance sheet by reducing the amount of debt accumulated over the past three years -- 2012 shows more than a 65% decrease in liabilities over the previous fiscal year.

  • We substantially increased our lab capacity and operations, as well as our calculational capacity, over the past nine months which will ultimately allow us to more rapidly increase the number of pathogen identifiers in the MIT 1000 library.

  • We submitted applications to the Association of Advanced Communities Research Institute (AOAC RI) for Performance Test Method Certification for the MIT 1000 for the identification of the pathogens E. coli and Salmonella.

  • We invested thousands in production design with our Hawthorne,

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->